BALANCE Diet Implementation in Primary Health Care: a Cluster Randomized Type II Hybrid Implementation Study
Implementa-MAC
Implementation of the Brazilian Cardioprotective Diet in Primary Health Care: a Cluster Randomized Type II Hybrid Implementation Study
1 other identifier
interventional
786
1 country
1
Brief Summary
This is an implementation type II hybrid study with randomisation in cluster, whose objective is to compare two strategies of implementation of the Brazilian cardioprotective diet guidelines in primary health care in two Brazilian cities. All health professionals from the health units (clusters) randomized to the intervention group will receive training on the subject. The health professionals from the health units randomized to the control group will follow the usual activities, receiving only the printed guidelines, as usually done. After 6 months, the prescription rate of the Brazilian cardioprotective diet will be evaluated, as well as the quality of the diet of patients in both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2022
CompletedFirst Posted
Study publicly available on registry
April 5, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2023
CompletedDecember 26, 2023
December 1, 2023
1.1 years
March 16, 2022
December 19, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Brazilian cardioprotective diet prescription rate
Implementation Primary Outcome (rate of eligible individuals who received Brazilian cardioprotective diet prescription)
6 months
food intake of 400g of vegetables per day
Eficacy Primary Outcome - number of patients that achieve the goal of eating 400g of vegetable/day
6 months
Secondary Outcomes (7)
Implementing the extra dietaty guidelines
6 months
Professionals' understanding of the Brazilian cardioprotective diet
right after intervention and 6 months after intervenions.
Patients' understanding of the Brazilian cardioprotective diet
right after intervention and 6 months after intervenions.
Patients' adherence to dietary guidelines
right after intervention and 6 months after intervenions.
Participants' weight
right after intervention and 6 months after intervenions.
- +2 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTAL1. Distribution of the Brazilian cardioprotective diet manual to primary health care 2. Training to prescribe the cardioprotective Brazilian diet. the training consists of 5 face-to-face modules lasting 4 hours each, in addition to a virtual module and group exercises. 3. Audit feedback
Control Group
NO INTERVENTIONDistribution of the Brazilian cardioprotective diet manual to primary health care professionals
Interventions
Eligibility Criteria
You may qualify if:
- Individuals aged ≥20 years of either sex who have a previous medical diagnosis of at least one of the following conditions:
- Type 2 diabetes mellitus;
- Systemic arterial hypertension (Systolic blood pressure ≥140 mmHg or diastolic blood pressure greater than ≥90 mmHg or in drug treatment for hypertension);
- Isolated hypercholesterolemia: isolated increase in LDL-c (LDL-c ≥ 160 mg/dL).
- Isolated hypertriglyceridemia: isolated increase in triglycerides (TG ≥ 150 mg/dL or ≥ 175 mg/dL if the sample is obtained without fasting).
- Obesity or overweight (body mass index ≥25.0 kg/m2).
You may not qualify if:
- Prior cardiovascular event (acute myocardial infarction, stroke, peripheral arterial disease);
- Psychiatric or neurocognitive condition that prevents understanding of guidelines (defined by the clinical judgment of the investigators);
- Life expectancy less than 6 months (example: metastatic malignant neoplasm) to be defined by the investigator's judgment;
- Pregnancy or lactation;
- Liver failure with a previous history of encephalopathy or anasarca;
- Chronic renal failure;
- Organ transplantation;
- Gastroplasty for less than a year;
- Impossibility of oral feeding.
- No access to internet or mobile phone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prefeitura Municipal de Foz do Iguaçu
Foz do Iguaçu, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2022
First Posted
April 5, 2022
Study Start
November 1, 2022
Primary Completion
November 30, 2023
Study Completion
December 19, 2023
Last Updated
December 26, 2023
Record last verified: 2023-12